PHI with Meniscal arthrosis
How does this condition affect your private health insurance?
Meniscus arthrosis, or meniscal arthropathy, refers to degenerative changes within the meniscus of the knee joint, often leading to or exacerbating osteoarthritis. It typically results from wear and tear, previous meniscal injuries (e.g., tears), or chronic stress. Symptoms include knee pain, stiffness, swelling, clicking, and reduced range of motion, particularly during weight-bearing activities. The condition can significantly impair mobility and quality of life, progressing over time if left untreated. While distinct from broader knee osteoarthritis, meniscal arthrosis frequently contributes to its development, impacting the joint's load distribution and shock absorption.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to a few months for initial symptomatic episodes, often subsiding with conservative treatment.
Duration of Illness (Lifetime)
Chronic and progressive; typically a lifelong condition requiring ongoing management.
Cost of Treatment (Initial)
EUR 500 - 3000 (diagnosis, physiotherapy, medication, injections).
Cost of Treatment (Lifetime)
EUR 5,000 - 30,000+ (includes potential surgery, long-term physiotherapy, medications, assistive devices, and repeated interventions).
Mortality Rate
Very low; not a direct cause of death.
Risk of Secondary Damages
High (e.g., chronic pain, reduced mobility, development of generalized knee osteoarthritis, muscle atrophy, psychological distress due to chronic pain).
Probability of Full Recovery
Low; while symptoms can be managed effectively, complete structural recovery of degenerative changes is rare.
Underlying Disease Risk
High (e.g., general knee osteoarthritis, obesity, previous knee injuries, inflammatory arthropathies, metabolic syndrome).